Total Chemical Synthesis of a SARS-CoV-2 Miniprotein Inhibitor LCB1.

Chen, Kai; Yu, Fei-Qiang; Zhang, Yan-Ni; Fang, Ge-Min

Chen, Kai; Yu, Fei-Qiang; Zhang, Yan-Ni; Fang, Ge-Min.

Afiliación

Chen K; Department of Health Sciences, Institutes of Physical Science and Information Technology, Anhui University, Hefei, China.
Yu FQ; Department of Health Sciences, Institutes of Physical Science and Information Technology, Anhui University, Hefei, China.
Zhang YN; Department of Health Sciences, Institutes of Physical Science and Information Technology, Anhui University, Hefei, China.
Fang GM; Department of Health Sciences, Institutes of Physical Science and Information Technology, Anhui University, Hefei, China. fanggm@ahu.edu.cn.

Methods Mol Biol ; 2530: 19-31, 2022.

Article en En | MEDLINE | ID: mdl-35761039

Asunto(s)

COVID-19; SARS-CoV-2; Humanos; Hidrazinas; Péptidos/química; Técnicas de Síntesis en Fase Sólida

Palabras clave

LCB1; Native chemical ligation; Peptide hydrazide; Solid-phase peptide synthesis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Revista: Methods Mol Biol Asunto de la revista: BIOLOGIA MOLECULAR Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google